ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
5,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
7,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
7,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
9,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
12,1,Deafness,Hearing losses,Hearing disorders,Ear,N
